reduced APD 50 and arrhythmic activity with 5-HT. Thus, the potentially arrhythmogenic influence of 5-HT may be suppressed in AF-remodelled human atrium.
Abstract:
5-hydroxytryptamine (5-HT) is pro-arrhythmic in atrial cells from patients in sinus rhythm (SR) via activation of 5-HT 4 receptors, but its effects in atrial cells from patients with atrial fibrillation (AF) are unknown. The whole-cell perforated patch-clamp technique was used to record L-type Ca 2+ current (I CaL ), action potential duration (APD) and arrhythmic activity at 37ºC in enzymatically-isolated atrial cells obtained from patients undergoing cardiac surgery, in SR or with chronic AF. In the AF group, 5-HT (10 µΜ) produced an increase in I CaL of 115±21% above control (n=10 cells, 6 patients) that was significantly smaller than that in the SR group (232±33%; p<0.05; n=27 cells, 12 patients). Subsequent co-application of isoproterenol (1 µΜ) caused a further increase in I CaL in the AF group (by 256±94%) that was greater than that in the SR group (22±6%; p<0.05). The APD at 50% repolarisation (APD 50 )
was prolonged by 14±3 ms by 5-HT in the AF group (n=37 cells, 14 patients). This was less than that in the SR group (27±4 ms; p<0.05; n=58 cells, 24 patients). Arrhythmic activity in response to 5-HT was observed in 22% of cells in the SR group, but none was observed in the
Introduction
Atrial fibrillation (AF) is the most common sustained arrhythmia in the developed word and its prevalence will increase with the ageing of the population [1] . The occurrence of AF may be related to structural heart disease, but in many cases there is not a clear aetiology. One of the factors that has been postulated to be responsible for the origin and maintenance of AF is the release of 5-hydroxytryptamine (5-HT, serotonin) from aggregating platelets in human atria [2, 3] . 5-HT is a naturally occurring monoamine, widely distributed in the animal kingdom, which exerts complex effects throughout the body, including the gastrointestinal and cardiovascular systems [4, 5] . 5-HT has been shown to act, via 5-HT 4 receptors [6] , as a positive inotropic, chronotropic and lusitropic agent in the human atrium [7] . 5-HT increases the L-type Ca 2+ current, I CaL , using the same biochemical pathway as isoproterenol (ISO), a β-adrenoceptor agonist, through activation of cyclic AMP [8] . The 5-HT-induced increase in peak I CaL density has been associated with a prolongation of the early plateau phase of the action potential duration (APD 50 ) and with arrhythmic activity in atrial myocytes from patients in sinus rhythm (SR) [9] . However, it is not known if the ability of 5-HT to increase I CaL , APD 50 and induce arrhythmic activity is preserved in atrial myocytes from patients with chronic AF. Another factor that may influence the arrhythmogenic potential of 5-HT is chronic β-adrenoceptor antagonist treatment of patients in SR prior to surgery [9] [10] [11] . The ability of 5-HT to increase I CaL , APD 50 and to cause arrhythmic activity in human atrial myocytes is increased by chronic β-blockade in myocytes from patients in SR [9] , but the influence of chronic β-blockade on the electrophysiological effects of 5-HT in myocytes from patients with AF is unknown. There has been only one previous study of 5-HT and AF, which showed a reduction of mRNA expression of 5-HT 4 receptors, but not of β-adrenoceptors, in the fibrillating human atrium [12] .
The aims of this study were to investigate the effects of 5-HT with and without ISO on I CaL , action potential duration (APD), cellular effective refractory period (cERP) and cellular arrhythmic depolarisations (cADs) in atrial myocytes from patients with chronic AF, and to compare these with the effects in atrial myocytes from patients in SR. We also assessed the influence of chronic treatment of patients with a β-adrenoceptor antagonist on the electrophysiological actions of 5-HT in atrial myocytes from patients with and without AF.
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Methods
Tissue and cell isolation
Procedures for obtaining human tissue were approved by the local ethical committee and conform to the institutional guidelines. This investigation conforms to the principles outlined in the Declaration of Helsinki [13] . Samples of the right atrial appendage were obtained from 81 consenting patients undergoing cardiac surgery; 66 in SR and 15 in chronic AF. Cardiac rhythm was determined from the pre-operative electrocardiogram, and duration of AF was confirmed from the patients' medical records. Atrial myocytes were isolated enzymatically as described previously [9] .
Electrical recording techniques
The whole-cell perforated patch-clamp technique was used to record I CaL , APD, cERP and cADs as described before [9] . 
Experimental protocols
The 
Data analysis and statistics
Cells were excluded from analysis if either the APD 50 or peak I CaL decreased irreversibly during the protocol. Concentration-response data for the effect of 5-HT on peak I CaL were fitted iteratively (Graphpad Prism) using a variable slope sigmoidal concentration-response curve.
Time-dependent inactivation of peak I CaL was fitted by a bioexponential function [21] . All data have been analysed using cell means, except when stated that patient means were used. Mean ±standard error of the mean (SEM) values were compared using paired or unpaired Student's ttest, with p<0.05 regarded as statistically significant. A Fisher's exact test was used to assess the incidences of arrhythmic activity between groups of cells. To permit sub-analysis within the SR group, data have been used from 27 patients in SR who were included in a previous publication [9] . 
Results
Patients' clinical characteristics
Clinical characteristics of patients in SR or with chronic AF (>6 months) are shown in Table 1 .
Those patients with prior treatment with β-adrenoceptor antagonists were treated for at least 1 week. In the SR group, the majority received a cardiac selective In the same set of cells, we analysed the kinetics properties of the time-dependent inactivation of basal and stimulated peak I CaL ( Table 2 ). The fast (τ 1 ) and the slow (τ 2 ) inactivation time constants were increased in cells from patients with AF compared to cells from patients in SR. 
Discussion
This study is the first, to our knowledge, to report that AF is associated with a reduction of the effects of 5-HT on I CaL and APD 50 in human atrial cells. This was associated with a loss of arrhythmic activity in cells from patients previously treated with a β-adrenoceptor antagonist.
The pro-arrhythmic actions of 5-HT in humans have been known for a long time [14] and support for its pro-arrhythmic effects has been reported in several studies from patients in SR The proarrhythmic activity induced by β-adrenoceptor agonists (e.g. isoproterenol) has been known for a long time [29] and their ability to increase I CaL via activation of the cyclic AMP cascade has been highlighted as the main trigger to induce afterdepolarisations in human atrial cells [29, 30] . Similarly, 5-HT, which activates the same biochemical pathway, has been demonstrated to induce pro-arrhythmic activity in atrial cells from patients in SR, particularly in those previously treated with β-adrenoceptor antagonists [9, 10] . The reduced efficacy and potency of 5-HT to increase I CaL in cells from patients with AF in the present study was associated with a loss of pro-arrhythmic activity by 5-HT, which may be directly linked to the reduced Ca 2+ entry [31] . ISO caused a greater increase in I CaL when compared to 5-HT in both the SR and AF groups, and this was associated with a greater incidence in the occurrence of arrhythmic activity. Similarly, it has been shown previously that the partial 5-HT 4 agonist prucalopride, in cells from patients in SR, caused reduced Ca 2+ entry when compared to 5-HT, and did not induce arrhythmic activity, while 5-HT, in the same cells, did [32] . In addition, the L-type Ca 2+ channel blocker nifedipine prevented the appearance of 5-HT/ISO-induced cADs, suggesting that increased I CaL and cellular Ca 2+ overload may play a major role in inducing cADs in human atrial cells [9, 31, 32] . Further studies, for example using a combination of electrophysiology and Ca 2+ imaging techniques, are needed to elucidate the mechanisms of the observed arrhythmic activity.
The slowing of the time-dependent I CaL inactivation in AF is consistent with other studies in which τ 1 and/or τ 2 , were increased in AF [17, 33] , possibly reflecting an adaptation to an altered activity of the SR Ca 2+ release channels and/or a reduced Ca 2+ influx through L-type Ca 2+ channels [34, 35] . By contrast, 5-HT and ISO decreased the fast time constant (τ 1 ) of I CaL inactivation in both the SR and AF groups, and shifted the fast phase to the slow phase, suggesting an enhanced Ca 2+ -dependent inactivation probably due the increased release of Ca
2+
by ryanodine receptors during stimulation [34] .
One important factor that may affect 5-HT response in human atrium is prior treatment with β-adrenoceptor antagonists [2, 9, 10, 36] . The present study indicated that chronic β-blockade consistent with other studies [37, 38] , but in contrast to other reports of no change in the APD 50 [39] or reduced APD 50 with AF [33, 40] . Since a maximal concentration of ISO was capable of further prolonging the APD 50 during perfusion with 5-HT, the prolonged basal APD 50 found with AF in our study was not preventing a further increase with 5-HT. While it has been reported that the levels of mRNA of human atrial 5-HT 4 -, β 1 -and β 2 -adreno-receptors were unaffected by chronic β-blockade in cells from patients with and without AF [12] , the interaction of complex "electrophysiological" [41] and "pharmacological" [42] remodelling processes may alter the balance of outward and inward currents which determine the APD 50 and attenuate the effect of chronic β-blockade on the I CaL responses to 5-HT. Tables   Table 1. Patients 
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